... in spending on new treatments for hepatitis C, cancer, diabetes and other chronic conditions were a key driver of increased drug spending in 2015, according to the new report from the IMS Institute for Healthcare Informatics, Medicines Use and Spending in the U.S.
No comments:
Post a Comment